NDC 64678-012 – Tembexa
Brincidofovir 10 mg/mL · Suspension · Oral
Product NDC64678-012
Product details
- Brand name
- Tembexa
- Generic name
- Brincidofovir
- Labeler
- Emergent BioDefense Operations Lansing LLC
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- NDA · NDA214460
- Marketed since
- April 20, 2022
- Listing expires
- December 31, 2026
Active ingredients
- Brincidofovir 10 mg/mL
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 64678-012-01 | 65 mL in 1 BOTTLE (64678-012-01) | Apr 20, 2022 |
| 64678-012-02 | 65 mL in 1 BOTTLE (64678-012-02) | Apr 20, 2022 |
| 64678-012-03 | 1 BOTTLE in 1 CARTON (64678-012-03) / 45 mL in 1 BOTTLE | Jul 23, 2025 |
| 64678-012-04 | 1 BOTTLE in 1 CARTON (64678-012-04) / 45 mL in 1 BOTTLE | Jul 23, 2025 |
Other Tembexa products
- 64678-010 Brincidofovir 100 mg/1 · Tablet, Film Coated · Emergent BioDefense Operations Lansing LLC